跳至主要内容
临床试验/CTRI/2023/08/056148
CTRI/2023/08/056148尚未招募3 期

Effect of adjunctive Memantine on cognitive functions, metabolic profile and brain neurometabolites in Clozapine-treated patients of Schizophrenia: A 1H-MRS Study - NI

Central Institute of Psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Inpatients satisfying the ICD 11-DCR criteria for Schizophrenia, supplemented with ICD 11 for Mortality and Morbidity Statistics (February 2022 edition).
  • 2.Score less than or equal to 25 in Montreal Cognitive Assessment.
  • 3.Patients who are on stable doses of Clozapine.
  • 4.Those who give informed consent for participating in the study.

排除标准

  • 1.Pregnancy.
  • 2.Lactating women, and female subjects of reproductive age without adequate contraception.
  • 3.Known hypersensitivity to Memantine.
  • 4.Co-medication with glutamate modulators.
  • 5.Major physical illnesses (Uncontrolled epilepsy, Myocardial infarction, Uncontrolled hypertension, Renal insufficiency, Liver failure.)
  • 6.Clinically diagnosed Intellectual disability.
  • 7.Past history of significant head injury.
  • 8.CDSS score more than 7 will not be included in study

研究者

相似试验